APA (7th ed.) Citation

D, Z., F, O., E, C., A, B., A, S., A, H., . . . M, N. (2023). Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition. European journal of nuclear medicine and molecular imaging, 50(9), 2621. https://doi.org/10.1007/s00259-023-06211-6

Chicago Style (17th ed.) Citation

D, Zboralski, et al. "Fibroblast Activation Protein Targeted Radiotherapy Induces an Immunogenic Tumor Microenvironment and Enhances the Efficacy of PD-1 Immune Checkpoint Inhibition." European Journal of Nuclear Medicine and Molecular Imaging 50, no. 9 (2023): 2621. https://doi.org/10.1007/s00259-023-06211-6.

MLA (9th ed.) Citation

D, Zboralski, et al. "Fibroblast Activation Protein Targeted Radiotherapy Induces an Immunogenic Tumor Microenvironment and Enhances the Efficacy of PD-1 Immune Checkpoint Inhibition." European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 9, 2023, p. 2621, https://doi.org/10.1007/s00259-023-06211-6.